Acer Therapeutics

Acer Therapeutics

Pharmaceuticals, 1 Gateway CTR Ste 351, Newton, Massachusetts, 02458, United States, 11-50 Employees

acertx.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 84********

Who is ACER THERAPEUTICS

Acer Therapeutics Inc. (Nasdaq: ACER) is a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases...

Read More

map
  • 1 Gateway CTR Ste 351, Newton, Massachusetts, 02458, United States Headquarters: 1 Gateway CTR Ste 351, Newton, Massachusetts, 02458, United States
  • 2013 Date Founded: 2013
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ACER THERAPEUTICS

Acer Therapeutics Org Chart and Mapping

Employees

Kevin Taylor

Director of Financial Reporting

Kim Tharaldsen

Executive Director, Patient Advocacy & Engagement

Eric Shaw-Moss

Director, IT Administration and Support Services

Heather Grot

Director Clinical Operations

Jeff Davis

Chief Business Officer

Joseph Auci

Vice President Market Access & Reimbursement

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Acer Therapeutics

Answer: Acer Therapeutics's headquarters are located at 1 Gateway CTR Ste 351, Newton, Massachusetts, 02458, United States

Answer: Acer Therapeutics's phone number is 84********

Answer: Acer Therapeutics's official website is https://acertx.com

Answer: Acer Therapeutics's revenue is $1 Million to $5 Million

Answer: Acer Therapeutics's SIC: 2834

Answer: Acer Therapeutics's NAICS: 325412

Answer: Acer Therapeutics has 11-50 employees

Answer: Acer Therapeutics is in Pharmaceuticals

Answer: Acer Therapeutics contact info: Phone number: 84******** Website: https://acertx.com

Answer: Acer Therapeutics Inc. (Nasdaq: ACER) is a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs. Acers pipeline includes four programs: ACER-001 (a taste-masked, immediate-release formulation of sodium phenylbutyrate) for the treatment of various inborn errors of metabolism, including urea cycle disorders (UCDs) and Maple Syrup Urine Disease (MSUD); emetine hydrochloride, a host-directed therapy against a variety of infectious diseases, initially for the treatment of patients with COVID-19; EDSIVOTM (celiprolol) for the treatment of vascular Ehlers-Danlos syndrome (vEDS) in patients with a confirmed type III collagen (COL3A1) mutation; and osanetant for the treatment of induced Vasomotor Symptoms (iVMS). Each of Acers product candidates is believed to present a comparatively de-risked profile, having one or more of a favorable safety profile, clinical proof-of-concept data, mechanistic differentiation and/or accelerated paths for development through specific programs and procedures established by the FDA. The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Acer's strategy is predicated upon time and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency. Acer has a strong company culture and is committed to creating and maintaining an environment that values individual rights, hard work, fosters creativity, and promotes success. The Company is growing and is fueled by the talent and expertise of our employees, driven by the commitment to treating patients with critical unmet medical needs.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access